TLX 1.54% $20.44 telix pharmaceuticals limited

Ann: Appendix 4C and Activities Report for June 2022 Quarter, page-9

  1. 397 Posts.
    lightbulb Created with Sketch. 53
    Agree. Fantastic result. This is what the analysts and (most) investors expected. I say most because some retail investors had unrealistically high expectations.

    If the trend continues with strong Illuccix sales and a favourable ZIRCON phase 3 trial read out, the next 6 months is going to be big.
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.